Inhibition of the TLR4/NF-κB pathway by curcumin nanoparticles (CNPs) to inhibit microglia polarization has been reported for the treatment of neuroinflammation in Alzheimer’s disease [125]. Here, NFKB1 is linked to Alzheimer disease.